norsteroids - CISMeF

Preferred Label : norsteroids;

MeSH definition : Steroids which have undergone contraction in ring size or reduction in side chains.;

Is substance : O;

Détails

Origin ID

D009654;

UMLS CUI

C0028401;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Norsteroid (substance) [SNOMED CT concept]
Record concept(s)
- norsteroids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (delta5,6-3-oxynorcholenyl)dimethylcarbinol [MeSH Supplementary Concept]
- 12-methyl-18-norcholesta-8,11,13-trien-3-ol [MeSH Supplementary Concept]
- 15-hydroxy-21-ketopristimerine [MeSH Supplementary Concept]
- 16,16-dimethyl-D-homo-19,B-dinor-8-isotestosterone [MeSH Supplementary Concept]
- 17-hydroxymethyl-17-methyl-18-norandrosta-1,4,13-trien-3-one [MeSH Supplementary Concept]
- 25,25-difluoro-27-nor-26-hydroxycholesterol [MeSH Supplementary Concept]
- 25,25-difluoro-27-norcholestenoic acid [MeSH Supplementary Concept]
- 25-((7-chloro-4-nitrobenz-2-oxa-1,3-diazole)methylamino)-27-norcholesterol [MeSH Supplementary Concept]
- 27-hydroxyceanothic acid [MeSH Supplementary Concept]
- 3,23-diacetoxy-24-nor-5-cholene [MeSH Supplementary Concept]
- 3-hydroxy-16-oxo-24-nor-17-azachol-5-eno-23-nitrile [MeSH Supplementary Concept]
- 3-hydroxy-19-nor-1,3,5(10)-cholatrien-24-oic acid [MeSH Supplementary Concept]
- 3-hydroxy-23,24-dinorcholano-22,16-lactone [MeSH Supplementary Concept]
- 3-hydroxy-5-hydroxy-B-norcholestane-6-carboxaldehyde [MeSH Supplementary Concept]
- 3-keto-23,24-bisnorchol-4-en-22-ol [MeSH Supplementary Concept]
- 3-oxa-A-norsteroid [MeSH Supplementary Concept]
- 3-sulfooxy-7-hydroxy-24-nor-5-cholenoic acid [MeSH Supplementary Concept]
- 3beta,11alpha-dihydroxyergosta-8,24(28)-dien-7-one [MeSH Supplementary Concept]
- 3beta-hydroxyergosta-8,24(28)-dien-7-one [MeSH Supplementary Concept]
- 5,8-epidioxy-24-norcholesta-6,9(11),22-trien-3-ol [MeSH Supplementary Concept]
- 5-hydroxy-6-formyl-7-norcholesterol [MeSH Supplementary Concept]
- 6-methyl-B-norandrostenedione [MeSH Supplementary Concept]
- 7-nor-ergosterolide [MeSH Supplementary Concept]
- Org 49209 [MeSH Supplementary Concept]
- acemosin [MeSH Supplementary Concept]
- ceanothetric acid [MeSH Supplementary Concept]
- ceanothic acid [MeSH Supplementary Concept]
- columnaristerol A [MeSH Supplementary Concept]
- crellasterone [MeSH Supplementary Concept]
- matsutoic acid [MeSH Supplementary Concept]
- nimbecidine [MeSH Supplementary Concept]
- norursocholic acid [MeSH Supplementary Concept]
- yibeinoside B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Norsteroid (substance) [SNOMED CT concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients